32. Pulpotomy (Er:YAG laser) versus pulpotomy (FC).
| Outcome | Time point (months) | No. of studies | Risk ratio (95% CI) |
| Clinical failure | 6 | 1 | Not estimable* |
| 12 | 1 | 3.19 (0.13 to 76.37) | |
| 24 | 1 | 2.13 (0.20 to 22.70) | |
| Radiological failure | 6 | 1 | Not estimable* |
| 12 | 1 | 1.60 (0.28 to 9.13) | |
| 24 | 1 | 1.06 (0.28 to 4.01) | |
| Overall failure | 6 | 1 | Not estimable* |
| 12 | 1 | 1.60 (0.28 to 9.13) | |
| 24 | 1 | 1.06 (0.28 to 4.01) | |
| Pain | 6, 12 and 24 | 1 | Not estimable* |
| Soft tissue pathology | 6 | 1 | Not estimable* |
| 12 | 1 | Not estimable* | |
| 24 | 1 | 0.35 (0.01 to 8.49) | |
| Pathological mobility | 6, 12 and 24 | 1 | Not estimable* |
| Pathological radiolucency | 6 | 1 | Not estimable* |
| 12 | 1 | 0.21 (0.01 to 4.31) | |
| 24 | 1 | 1.06 (0.16 to 7.25) | |
| Pathological root resorption | 6 | 1 | Not estimable* |
| 12 | 1 | 3.19 (0.13 to 76.37) | |
| 24 | 1 | 1.06 (0.16 to 7.25) |
*due to lack of events
Abbreviations ‐ CI: confidence interval; Er:YAG: erbium:yttrium‐aluminium garnet; FC: formocresol